Cited by 1,772Liver Disease Diagnosis and TreatmentLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Molecular mediators of hepatic steatosis and liver injury

Open access

Browning, Jeffrey D., Horton, Jay D.·2004·Journal of Clinical Investigation

DOI 10.1172/jci200422422PMC PMC449757

Open this paper in CoChat — free account Open PDF

Abstract

Nonstandard abbreviations used: acetyl-CoA carboxylase (ACC); AMP-activated protein kinase (AMPK); basic helix-loop-helix-leucine zipper (bHLH-Zip); carbohydrate response element binding protein (ChREBP); carnitine palmitoyl transferase-1 (CPT-1); diethylaminoethoxyhexestrol (DEAEH); liver function test (LFT); liver-type pyruvate kinase (L-PK); malondialdehyde (MDA); mitochondrial respiratory chain (MRC); nonalcoholic fatty-liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); polyunsaturated fatty acid (PUFA); reactive oxygen species (ROS); stearoyl-CoA desaturase (SCD); trans-4-hydroxy-2-nonenal (HNE). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci200422422

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citation
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166

Show all 82 references

Research works printed but not linked: 1

Garcia-Ruiz, 1995, Mol. Pharmacol., 48, 825

Sorted by citations

Items 301–400 of 1,005

Adiponectin and alcoholic fatty liver disease
Rogers, C. Q., Ajmo, J. M., & You, M. (2008) · IUBMB Life · doi:10.1002/iub.124 · Cited by 139
Effects of ovariectomy on PPARα, SREBP-1c, and SCD-1 gene expression in the rat liver
Paquette, A., Wang, D., Jankowski, M., Gutkowska, J., & Lavoie, J.-M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31817b8159 · Cited by 137
Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice
Kawanishi, N., Yano, H., Mizokami, T., Takahashi, M., Oyanagi, E., & Suzuki, K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.04.006 · Cited by 136
Sphingolipids in High Fat Diet and Obesity‐Related Diseases
Choi, S., & Snider, A. J. (2015) · Mediators of Inflammation · doi:10.1155/2015/520618 · Cited by 136
Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity
Sato, S., & Mukai, Y. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s228361 · Cited by 136
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance
Sun, N., Shen, C., Zhang, L., Wu, X., Yu, Y., Yang, X., Chen, Y., Zhong, C., Gao, Z., Miao, W., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321774 · Cited by 136
Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism
Miyazaki, M. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.707 · Cited by 135
Mechanisms of intrahepatic triglyceride accumulation
Ress, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1664 · Cited by 135
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
Honda, Y., Kessoku, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Takizawa, T., Saito, S., Nagashima, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep42477 · Cited by 135
Hepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients.
Wu, T., Liu, Y., Fu, Y., Liu, X., & Zhou, X.-H. (2014) · PubMed · Cited by 134
Ratiometric photoacoustic imaging of endoplasmic reticulum polarity in injured liver tissues of diabetic mice
Xiao, H., Wu, C., Li, P., Gao, W. Z., Zhang, W., Zhang, W., Tong, L., & Tang, B. (2017) · Chemical Science · doi:10.1039/c7sc02330h · Cited by 134
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
Sasaki, A., Nitta, H., Otsuka, K., Umemura, A., Baba, S., Obuchi, T., & Wakabayashi, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00164 · Cited by 133
Renal Lipid Metabolism and Lipotoxicity in Diabetes
Thongnak, L., Pongchaidecha, A., & Lungkaphin, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.11.004 · Cited by 133
Alloxan-Induced Diabetes Causes Morphological and Ultrastructural Changes in Rat Liver that Resemble the Natural History of Chronic Fatty Liver Disease in Humans
Lucchesi, A. N., Cassettari, L. L., & Spadella, C. T. (2015) · Journal of Diabetes Research · doi:10.1155/2015/494578 · Cited by 132
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
Hanin, G., Yayon, N., Tzur, Y., Haviv, R., Bennett, E. R., Udi, S., Krishnamoorthy, Y. R., Kotsiliti, E., Zangen, R., Efron, B., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312869 · Cited by 132
The metabolic syndrome in overweight epileptic patients treated with valproic acid
Verrotti, A., Manco, R., Agostinelli, S., Coppola, G., & Chiarelli, F. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02206.x · Cited by 134
Ferulic acid improves lipid and glucose homeostasis in high‐fat diet‐induced obese mice
Naowaboot, J., Piyabhan, P., Munkong, N., Parklak, W., & Pannangpetch, P. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12514 · Cited by 131
Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities
Syed‐Abdul, M. M., Parks, E. J., Gaballah, A. H., Bingham, K., Hammoud, G. M., Kemble, G. W., BUCKLEY, D. I., McCulloch, W. F., & Manrique‐Acevedo, C. (2019) · Hepatology · doi:10.1002/hep.31000 · Cited by 131
A Comprehensive Untargeted Metabonomic Analysis of Human Steatotic Liver Tissue by RP and HILIC Chromatography Coupled to Mass Spectrometry Reveals Important Metabolic Alterations
García‐Cañaveras, J. C., Donato, M. T., Castell, J. V., & Lahoz, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200629p · Cited by 130
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.
Koska, J., Stefan, N., Permana, P. A., Weyer, C., Sonoda, M., Bogardus, C., Smith, S. R., Joanisse, D. R., Funahashi, T., Krakoff, J., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.295 · Cited by 129
Rutin Inhibits Oleic Acid Induced Lipid Accumulation via Reducing Lipogenesis and Oxidative Stress in Hepatocarcinoma Cells
Wu, C., Lin, M., Wang, H., Yang, M., Jou, M., & Wang, C. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.02033.x · Cited by 129
Bilirubin Links Heme Metabolism to Neuroprotection by Scavenging Superoxide
Vasavda, C., Kothari, R., Malla, A. P., Tokhunts, R. A., Lin, A. L., Ji, M., Ricco, C., Xu, R., Saavedra, H. G., Sbodio, J. I., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.006 · Cited by 129
A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis
Griffett, K., Solt, L. A., Elgendy, B., Kamenecka, T. M., & Burris, T. P. (2012) · ACS Chemical Biology · doi:10.1021/cb300541g · Cited by 129
Role of thymol on hyperglycemia and hyperlipidemia in high fat diet-induced type 2 diabetic C57BL/6J mice
Saravanan, S., & Pari, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.034 · Cited by 129
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Yu, S. J., Kim, W. K., Kim, D., Yoon, J., Lee, K., Kim, J. H., Cho, E. J., Lee, J., Kim, H. Y., Kim, Y. J., et al. (2015) · Medicine · doi:10.1097/md.0000000000002159 · Cited by 128
Infliximab Restores Glucose Homeostasis in an Animal Model of Diet-Induced Obesity and Diabetes
ARAUJO, E. P. D., de Souza, C. T., Ueno, M., Cintra, D. E., Bértolo, M. B., Carvalheira, J. B. C., Saad, M. J. A., & Velloso, L. A. (2007) · Endocrinology · doi:10.1210/en.2007-0132 · Cited by 128
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
Tissue Inhibitor of Metalloproteinase 3 Deficiency Causes Hepatic Steatosis and Adipose Tissue Inflammation in Mice
Menghini, R., Menini, S., Amoruso, R., Fiorentino, L., Casagrande, V., Marzano, V., Tornei, F., Bertucci, P., Iacobini, C., Sérino, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.079 · Cited by 127
Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index
Alatalo, P., Koivisto, H., Hietala, J., Puukka, K. S., Bloigu, R., & Niemelä, O. J. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1097 · Cited by 127
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 125
Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment
Leite, N. C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8377 · Cited by 125
Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver
Liu, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14672 · Cited by 125
Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study
Nobili, V., Manco, M., Ciampalini, P., Alisi, A., Vito, R. D., Bugianesi, E., MARCELLINI, M., & Marchesini, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.06.012 · Cited by 125
Zebrafish: An emerging model system to study liver diseases and related drug discovery
Katoch, S., & Patial, V. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4031 · Cited by 124
Review article: role of oxidative stress in the progression of non‐alcoholic steatosis
Albano, E., Mottaran, E., Occhino, G., Reale, E., & Vidali, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02601.x · Cited by 124
CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism
Peterson, J. M., Seldin, M. M., Wei, Z., Aja, S. M., & Wong, G. W. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00102.2013 · Cited by 123
Dietary glycemic index and liver steatosis
Valtueña, S., Pellegrini, N., Ardigò, D., Rio, D. D., Numeroso, F., Scazzina, F., Monti, L. D., Zavaroni, I., & Brighenti, F. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.136 · Cited by 123
Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice
Wang, G., Huang, W., Xia, Y., Xiong, Z., & Ai, L. (2019) · Food & Function · doi:10.1039/c8fo02181c · Cited by 122
SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver
Li, X., Huang, W., Gu, J., Du, X., Lei, L., Yuan, X., Sun, G., Wang, Z., Li, X., & Liu, G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.011 · Cited by 121
Nutraceuticals and Functional Foods in the Management of Hyperlipidemia
Chen, G., Wang, H., Zhang, X., & Yang, S. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.629354 · Cited by 121
Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver
Garcı́a-Villafranca, J., Guillén, A., & Castro, J. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.019 · Cited by 121
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
Jacobson, I. M., Davis, G. L., El‐Serag, H. B., Negro, F., & TREPO, C. G. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.032 · Cited by 121
Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats
Fisher, C. D., Lickteig, A. J., Augustine, L. M., Elferink, R. P. J. O., Besselsen, D. G., Erickson, R. P., & Cherrington, N. J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.002 · Cited by 121
Apolipoprotein A-IV Expression in Mouse Liver Enhances Triglyceride Secretion and Reduces Hepatic Lipid Content by Promoting Very Low Density Lipoprotein Particle Expansion
VerHague, M., Cheng, D., Weinberg, R. B., & Shelness, G. S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301948 · Cited by 120
Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis
Zeisel, S. H. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0518 · Cited by 119
Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters
Guo, F., Huang, C., Liao, X., Wang, Y., He, Y., Feng, R., Li, Y., & Sun, C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100392 · Cited by 118
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
Rabinowich, L., & Shibolet, O. (2015) · BioMed Research International · doi:10.1155/2015/168905 · Cited by 118
AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress
Choi, S. H., Kim, Y. W., & Kim, S. G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.011 · Cited by 118
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
Pinkosky, S. L., Groot, P. H. E., Lalwani, N. D., & Steinberg, G. R. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.09.001 · Cited by 118
Metabolic Changes of Hepatocytes in NAFLD
Lu, Q., Tian, X., Wu, H., Huang, J., Li, M., Mei, Z., Zhou, L., Xie, H., & Zheng, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710420 · Cited by 118
Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence?
García‐Ruiz, C., Baulies, A., Marí, M., García-Rovés, P. M., & Fernández-Checa, J. C. (2013) · Free Radical Research · doi:10.3109/10715762.2013.830717 · Cited by 119
Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels
Dahlhoff, C., Worsch, S., Sailer, M., Hummel, B., Fiamoncini, J., Uebel, K., Obeid, R., Scherling, C., Geisel, J., Bader, B., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.010 · Cited by 118
Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes
Sahini, N., & Borlak, J. T. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.02.002 · Cited by 117
Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T., Tanaka, N., Suzuki, T., Sano, K., Horiuchi, A., Komatsu, M., Nakajima, T., Nishizawa, T., Joshita, S., Umemura, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.033 · Cited by 117
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 118
Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets
Lee, Y. M., Choi, J. S., Kim, M. H., Jung, M. H., Lee, Y. S., & Song, J. (2006) · Nutrition · doi:10.1016/j.nut.2005.12.014 · Cited by 116
Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver
Davaatseren, M., Hur, H. J., Yang, H. J., Hwang, J., Park, J. H., Kim, H., Kim, M. J., Kwon, D. Y., & Sung, M. J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.023 · Cited by 116
Microparticles Release by Adipocytes Act as “Find-Me” Signals to Promote Macrophage Migration
Eguchi, A., Mulya, A., Lazić, M., Radhakrishnan, D., Berk, M. P., Povero, D., Górnicka, A., & Feldstein, A. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123110 · Cited by 116
Natural isothiocyanates: Genotoxic potential versus chemoprevention
Fimognari, C., Turrini, E., Ferruzzi, L., Lenzi, M., & Hrelia, P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.001 · Cited by 116
The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
Lee, I. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.181 · Cited by 116
The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population
Dong, H., Wang, J., Li, C., Hirose, A., Nozaki, Y., Takahashi, M., Ono, M., Akisawa, N., Iwasaki, S., Saibara, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.12.012 · Cited by 116
High fat diet‐induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia
Carabelli, J., Burgueño, A. L., Rosselli, M. S., Gianotti, T. F., Lago, N. R., Pirola, C. J., & Sookoian, S. C. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01128.x · Cited by 116
Differential alterations in mitochondrial function induced by a choline-deficient diet: Understanding fatty liver disease progression
Teodoro, J. S., Rolo, A. P., Duarte, F. V., Simões, A. M., & Palmeira, C. M. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.07.008 · Cited by 116
High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism
Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 117
Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine
Noureddin, M., Mato, J. M., & Lu, S. C.-L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215579161 · Cited by 116
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice
Singh, A. K., Chaube, B., Zhang, X., Sun, J., Citrin, K. M., Canfrán-Duque, A., Aryal, B., Rotllan, N., Varela, L., Lee, R. G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140989 · Cited by 115
Nrf2 Inhibits LXRα-Dependent Hepatic Lipogenesis by Competing with FXR for Acetylase Binding
Kay, H. Y., Kim, W., Hwang, S. J., Choi, H., Gilroy, R. K., Wan, Y. Y., & Kim, S. G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3834 · Cited by 115
Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Das, S. K., & Balakrishnan, V. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-011-0121-7 · Cited by 114
Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver
Guillén, N., Navarro, M. Á., Arnal, C., Noone, E., Arbonés-Mainar, J. M., Acı́n, S., Surra, J. C., Muniesa, P., Roche, H. M., & Osada, J. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90339.2008 · Cited by 113
MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
Iglesias, P., Selgas, R., Romero, S., & Díez, J. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0357 · Cited by 113
Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes
Sandhya, N., Gokulakrishnan, K., Rangasamy, S., Syed, F., Ravikumar, R., Mohan, V., & Balasubramanyam, M. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.04.003 · Cited by 113
Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome
Libby, A. E., Bales, E. S., Orlicky, D. J., & McManaman, J. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759795 · Cited by 111
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Ali, R., & Cusi, K. J. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 111
Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein
Wu, Y., Peng, X., Zhu, Y., Yan, X., Chen, W.-N., & Xu, L. (2015) · Journal of Virology · doi:10.1128/jvi.02604-15 · Cited by 110
Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway
Zhao, Z., Wang, C., Zhang, L. R., Zhao, Y., Duan, C., Zhang, X., Gao, L., & Li, S. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09703-4 · Cited by 110
Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
Tanaka, S., Miyanishi, K., Kobune, M., Kawano, Y., Hoki, T., Kubo, T., Hayashi, T., Sato, T., Sato, Y., Takimoto, R., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0739-0 · Cited by 110
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
Pihlajamäki, J., Kuulasmaa, T., Kamińska, D., Simonen, M., Kärjä, V. J., Grönlund, S., Käkelä, P., Pääkkönen, M. E., Kainulainen, S., Punnonen, K. R. A., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.005 · Cited by 109
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Fruci, B., Giuliano, S., Mazza, A., Malaguarnera, R., & Belfiore, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122933 · Cited by 109
Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice
Sheng, X., Wang, M., Lu, M., Xi, B., Sheng, H., & Zang, Y. Q. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00332.2010 · Cited by 108
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
Mastroianni, C. M., Lichtner, M., Mascia, C., Zuccalà, P., & Vullo, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069184 · Cited by 108
Heme Oxygenase-1 Induction by the Clinically Used Anesthetic Isoflurane Protects Rat Livers From Ischemia/Reperfusion Injury
Schmidt, R., Tritschler, E., Hoetzel, A., Loop, T., Humar, M., Halverscheid, L., Geiger, K. K., & Pannen, B. H. J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000256891.45790.4d · Cited by 108
Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet
Santamarina, A. B., de Oliveira, J. L., da Silva, F. P., Carnier, J., Mennitti, L. V., de Santana, A. A., Gabriel, H. I. D. S., Ribeiro, E. B., do Nascimento, C. M. O., Lira, F. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141227 · Cited by 108
Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity
Walle, P., Takkunen, M. J., Männistö, V., Vaittinen, M., Lankinen, M. A., Kärjä, V. J., Käkelä, P., Ågren, J., Tiainen, M., Schwab, U., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.011 · Cited by 108
Hepatic Steatosis in Type 1 Diabetes
Regnell, S. E., & Lernmark, Å. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.454 · Cited by 108
Metabolic Consequences of Sleep-Disordered Breathing
Jun, J. C., & Polotsky, V. Y. (2009) · ILAR Journal · doi:10.1093/ilar.50.3.289 · Cited by 107
Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Sankatsing, R. R., Fouchier, S. W., de Haan, S., Hutten, B. A., de Groot, E., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176191.64314.07 · Cited by 106
Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats
Kim, S., Park, S. W., Sin, H., Jang, S., Lee, S.-W., Kim, S., Kwon, B., Yu, K.-Y., Kim, S. Y., & Yang, D. K. (2017) · Nutrients · doi:10.3390/nu9030293 · Cited by 106
Versatile Histochemical Approach to Detection of Hydrogen Peroxide in Cells and Tissues Based on Puromycin Staining
Chung, C. Y., Timblin, G. A., Saijo, K., & Chang, C. J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02279 · Cited by 106
The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
Bricambert, J., Alves‐Guerra, M., Estèves, P., Prip‐Buus, C., Bertrand‐Michel, J., Guillou, H., Chang, C. J., Wal, M. N. V., Canonne‐Hergaux, F., Mathurin, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04361-y · Cited by 106
Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances
Abdelmegeed, M. A., Ha, S.-K., Choi, Y., Akbar, M. D., & Song, B. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467208666150817111114 · Cited by 106
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
VILAR GOMEZ, E., RODRIGUEZ DE MIRANDA, A., GRA ORAMAS, B., ARUS SOLER, E., LLANIO NAVARRO, R., CALZADILLA BERTOT, L., YASELLS GARCIA, A., & DEL ROSARIO ABREU VAZQUEZ, M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04122.x · Cited by 105
Inflammatory Mediators of Hepatic Steatosis
Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 105
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
Kutlu, Ö., Kaleli, H. N., & Ozer, E. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8543763 · Cited by 105
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease
Zarrinpar, A., & Loomba, R. S. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 104
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice
Toye, A. A., Dumas, M., Blancher, C., Rothwell, A. R., Fearnside, J., Wilder, S. P., Bihoreau, M.-T., Cloarec, O., Azzouzi, I., Young, S., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0738-5 · Cited by 104
Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential inLiver for the Metabolism of ExcessAcyl-CoAs
Hammond, L. E., Neschen, S., Romanelli, A. J., Cline, G. W., Ilkayeva, O., Shulman, G. I., Muoio, D. M., & Coleman, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503181200 · Cited by 104
Effect of Endurance Exercise on Hepatic Lipid Content, Enzymes, and Adiposity in Men and Women
Devries, M. C., Samjoo, I. A., Hamadeh, M. J., & Tarnopolsky, M. A. (2008) · Obesity · doi:10.1038/oby.2008.358 · Cited by 103
Lipid droplets and hepatitis C virus infection
McLauchlan, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.012 · Cited by 103
DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
Rong, S., Xia, M., Vale, G., Wang, S., Kim, C.-W., Li, S., McDonald, J. G., Radhakrishnan, A., & Horton, J. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.011 · Cited by 102
Self-citation

Authors: Browning, J. D., & Horton, J. D.
Affiliations: The University of Texas Southwestern Medical Center (US)
Corresponding author: Horton, Jay D.
ORCID: Horton, Jay D.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 147-152
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200422422
PMC: PMC449757
OpenAlex: W4230280576
Cited by: 1,772
References: 82
Citations by year: 2026: 18 · 2025: 32 · 2024: 45 · 2023: 50 · 2022: 73 · 2021: 72 · 2020: 75 · 2019: 100 · 2018: 104 · 2017: 89 · 2016: 102 · 2015: 109 · 2014: 90 · 2013: 104 · 2012: 103
FWCI: 48.64
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
Funders: American Liver Foundation
National Institutes of Health (HL20948)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: hepatic steatosis, liver injury, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, molecular mediators, lipid metabolism, reactive oxygen species, oxidative stress, mitochondrial dysfunction, lipid peroxidation, acetyl-CoA carboxylase, AMPK, ChREBP, stearoyl-CoA desaturase, polyunsaturated fatty acids, malondialdehyde

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mediators of hepatic steatosis and liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks